Table 4.

Case series of patients with liver malignancies other than HCC who received TIPS placement

Author	Enrolled patients with liver malignancies + TIPS	Liver malignancy	Indication for TIPS	Technical success (%)	Post-TIPS HE (%)
Shreve L, et al. 2022 [72]	9	Colorectal cancer (n = 5) NET (n = 3) malignant haemangioendothelioma (n = 1)	Acute variceal bleeding, refractory ascites	89	67
Geeroms B, et al. 2018 [71]	3	Breast cancer (n = 3)	Refractory ascites	100	NA

HCC: Hepatocellular carcinoma; TIPS: Transjugular intrahepatic portosystemic shunt; HE: hepatic encephalopathy; NET: neuroendocrine tumour; NA: not available